Episode 6 : Impact of syndromic testing on patient clinical outcom

Episode 9 : ESCMID Special: Driving Change in Antimicrobial Stewardship with DRIVE-AMS

In this special episode recorded at ESCMID 2026 in Munich, we welcome Dr Jeroen Schouten and Dr Francisco Almeida to explore how the DRIVE-AMS program is transforming antimicrobial stewardship through behavioral change. Together, they discuss how data-driven interventions, tailored feedback, and multidisciplinary collaboration can sustainably improve prescribing practices across hospitals.   ---------------------------------------- Hosted on Acast. See acast.com/privacy [https://acast.com/privacy] for more information.

Episode 8 : Fast PCR testing for Pneumonia in ICU

In this episode, we talk with two critical care and microbiology experts from Kuwait. They discuss how rapid diagnostics, particularly multiplex PCR testing, are transforming pneumonia management in intensive care by enabling faster, more targeted treatment, supporting antimicrobial stewardship, and improving patient outcomes. ---------------------------------------- Hosted on Acast. See acast.com/privacy [https://acast.com/privacy] for more information.

Episode 7: Impact of point-of-care testing (POCT) in children.

In this episode, we talk with two pediatric experts from Dubai. They discuss the role and impact of point-of-care testing (POCT) in children, showing how rapid diagnostics support better clinical decisions, help avoid unnecessary hospitalizations, and reduce costs through more efficient patient management.   ---------------------------------------- Hosted on Acast. See acast.com/privacy [https://acast.com/privacy] for more information.

Episode 6 : Impact of syndromic testing on patient clinical outcom

In this special ESCMID episode, Dr Shradha Subedi and Dr Umang Agrawal introduce their latest studies on the impact of rapid syndromic testing; one conducted in Australia, the other in India. Together, they discuss how these diagnostics influence clinical decisions, the contrasts in patient management across regions, and the broader implications for the antimicrobial landscape. ---------------------------------------- Hosted on Acast. See acast.com/privacy [https://acast.com/privacy] for more information.

Episode 5 : ESCMID special – Monitoring Antimicrobial resistance with the Global-PPS

In this special episode, recorded at ESCMID 2025 in Vienna, we are pleased to welcome two AMR experts: Erika Vlieghe and Ann Versporten. They reveal the impact of the powerful Global Point Prevalence Survey program and highlight its crucial role in tracking antimicrobial use and resistance, sharing rich insights from global implementation ---------------------------------------- Hosted on Acast. See acast.com/privacy [https://acast.com/privacy] for more information.